Generic pharmaceutical company Sandoz has hit back in an intellectual property lawsuit by Merck Sharp & Dohme, filing a cross-claim that seeks to undo an extension of time granted to the US drug manufacturer for a patent relating to its multibillion dollar Januvia and Janumet diabetes drugs.
ANZ will fight to keep a sacked trader from accessing a client file held by HWL Ebsworth, citing privilege over the documents, a court has heard.
After months of uncertainty and a scolding from the judge about “vague” excuses, former Linchpin Capital directors facing proceedings by ASIC and a class of investors have been given assurance that their legal costs will be covered under an insurance policy.
An accountant who was kicked out of an Australia and New Zealand accounting association after a court found he sexually harassed a colleague has failed to win readmission after being unable to find an eligible member who could vouch for him in a character reference.
Engineering company UGL Limited is facing an employment class action on behalf of casual aluminium construction and manufacturing workers who were allegedly underpaid for over three years.
A legal battle in the Federal Court between Freedom Foods and Blue Diamond Growers over an almond milk licensing deal has been stayed so the parties can arbitrate their dispute in California, where the Australian Consumer Law will apply.
Seven Network has resolved a lawsuit brought by game show host and news presenter Simon Reeve seeking compensation and pecuniary penalties after his sudden dismissal in June during the height of the COVID-19 pandemic.
An investor who sank $1 million into a now suspended Mayfair Group scheme has lost his misleading and deceptive conduct case against the firm, with a judge finding his evidence was “plainly coloured” by the fact he had lost his life savings.
A judge has ordered that defunct Dover Financial Advisors and its former director pay $1.4 million in penalties for creating a misleading client protection policy he described as “an exercise in Orwellian doublespeak.”
Health care giant Healius has lost its application to the High Court to challenge a $60 million win for the Australian Taxation Office.